ProfileGDS4718 / 204314_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 82% 80% 86% 77% 83% 83% 83% 79% 83% 82% 82% 83% 83% 83% 84% 83% 84% 84% 81% 85% 78% 80% 84% 81% 81% 84% 79% 82% 84% 85% 84% 84% 80% 83% 79% 83% 81% 82% 81% 88% 82% 83% 83% 83% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.0763582
GSM549102patient 115, normal, homogenized [OPG study]7.827980
GSM549104patient 119, normal, homogenized [OPG study]8.7034586
GSM549108patient 138, normal, homogenized [OPG study]7.4641777
GSM549119patient 077, normal, homogenized [OPG study]8.1924383
GSM549133patient 032, cancer, homogenized [OPG study]8.3971383
GSM549139patient 042, cancer, homogenized [OPG study]8.2328883
GSM549099patient 107, normal, homogenized [OPG study]7.6563179
GSM549109patient 139, normal, homogenized [OPG study]8.1876283
GSM549110patient 046, normal, homogenized [OPG study]8.0928582
GSM549114patient 063, normal, homogenized [OPG study]8.1636882
GSM549122patient 082, normal, homogenized [OPG study]8.2067583
GSM549134patient 033, cancer, homogenized [OPG study]8.2455283
GSM549136patient 036, cancer, homogenized [OPG study]8.2550283
GSM549140patient 044, cancer, homogenized [OPG study]8.3612284
GSM549111patient 047, normal, homogenized [OPG study]8.2211383
GSM549113patient 057, normal, homogenized [OPG study]8.4830584
GSM549132patient 031, cancer, homogenized [OPG study]8.3111284
GSM549137patient 038, cancer, homogenized [OPG study]8.0215381
GSM549142patient 047, cancer, homogenized [OPG study]8.095285
GSM549100patient 110, normal, homogenized [OPG study]7.5287578
GSM549107patient 135, normal, homogenized [OPG study]7.8744780
GSM549115patient 068, normal, homogenized [OPG study]8.5120384
GSM549116patient 072, normal, homogenized [OPG study]8.0645481
GSM549120patient 078, normal, homogenized [OPG study]8.0131681
GSM549131patient 030, cancer, homogenized [OPG study]8.5050784
GSM549118patient 074, normal, homogenized [OPG study]7.7615179
GSM549129patient 027, cancer, homogenized [OPG study]8.1242682
GSM549123patient 088, normal, homogenized [OPG study]8.3164284
GSM549124patient 006, cancer, homogenized [OPG study]8.36785
GSM549126patient 015, cancer, homogenized [OPG study]8.3207384
GSM549128patient 025, cancer, homogenized [OPG study]8.4247784
GSM549103patient 117, normal, homogenized [OPG study]7.7482580
GSM549117patient 073, normal, homogenized [OPG study]8.3068283
GSM549138patient 041, cancer, homogenized [OPG study]7.769479
GSM549141patient 045, cancer, homogenized [OPG study]8.3428883
GSM549130patient 028, cancer, homogenized [OPG study]7.9275981
GSM549101patient 111, normal, homogenized [OPG study]8.0272382
GSM549105patient 128, normal, homogenized [OPG study]7.8853881
GSM549106patient 134, normal, homogenized [OPG study]9.0867988
GSM549112patient 048, normal, homogenized [OPG study]8.0610982
GSM549125patient 011, cancer, homogenized [OPG study]8.1664683
GSM549127patient 024, cancer, homogenized [OPG study]8.1821783
GSM549135patient 035, cancer, homogenized [OPG study]8.2874983